ENDRA Life Sciences Inc.

The momentum for this stock is not very good. ENDRA Life Sciences Inc. is not very popular among insiders. ENDRA Life Sciences Inc. is a mediocre stock to choose.
Log in to see more information.
ENDRA Life Sciences, Inc. engages in the development of ultrasound technology for the pre-clinical r...

News

ENDRA Life Sciences Strives for Nasdaq Compliance
ENDRA Life Sciences Strives for Nasdaq Compliance

TipRanks Financial Blog ENDRA Life Sciences (NDRA) just unveiled an announcement. ENDRA Life Sciences Inc. has announced that they've received additional time from a Nasdaq Hearing Panel t...\n more…

ENDRA Life Sciences granted extension to regain compliance with Nasdaq continued listing requirements
ENDRA Life Sciences granted extension to regain compliance with Nasdaq continued listing requirements

Seeking Alpha - Healthcare ENDRA Life Sciences granted extension to regain compliance with Nasdaq continued listing requirements...\n more…

ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements
ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements

Business Wire ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS), today announced that on August 27, 2024, the Company was notified by The Nasdaq Stock Market LLC...\n more…

ENDRA Life Sciences Inc. (NDRA) Q2 2024 Earnings Call Transcript
ENDRA Life Sciences Inc. (NDRA) Q2 2024 Earnings Call Transcript

Seeking Alpha: Transcripts ENDRA Life Sciences Inc. (NDRA) Q2 2024 Earnings Call Transcript...\n more…

Endra Life Sciences GAAP EPS of -$0.08 misses by $0.01
Endra Life Sciences GAAP EPS of -$0.08 misses by $0.01

SeekingAlpha.com: All News Endra Life Sciences (NDRA) reports Q2 GAAP EPS of -$0.08, missing by $0.01.\n more…

ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update
ENDRA Life Sciences Reports Second Quarter 2024 Financial Results and Provides a Business Update

Business Wire ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS), reports financial results for the three and six months ended June 30, 2024, as filed in a Form 10-Q...\n more…